JS04.5.A HEMIZYGOUSCDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS
Kocakavuk E, Johnson K, Sabedot T, Reinhardt H, Noushmehr H, Verhaak R. JS04.5.A HEMIZYGOUSCDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS. Neuro-Oncology 2023, 25: ii8-ii8. PMCID: PMC10489854, DOI: 10.1093/neuonc/noad137.021.Peer-Reviewed Original ResearchWorse OSCDKN2A deletionCDKN2A statusIDH-mutant gliomasPrognostic valueMultivariable Cox regression models